Article
Selection of a PD ‐1 blocking antibody from a novel fully human phage display library
1 Nov 2022
Abstract excerpt
Abstract Programmed cell death protein 1 (PD‐1) is an immunoregulatory target which is recognized by different monoclonal antibodies, approved for the therapy of multiple types of cancer. Different anti‐PD‐1 antibodies display different therapeutic properties and there is a pharmaceutical interest to generate and characterize novel anti‐PD‐1 antibodies. We screened multiple human antibody phage display libraries...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
